Tetrahydrobiopterin increases NO-dependent vasodilation in hypercholesterolemic human skin through eNOS-coupling mechanisms

Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15;304(2):R164-9. doi: 10.1152/ajpregu.00448.2012. Epub 2012 Nov 28.

Abstract

Localized exogenous R-tetrahydrobiopterin (R-BH(4)) corrects the deficit in local heat-induced vasodilation (VD) in hypercholesterolemic (HC) human skin through one of two plausible mechanisms: by serving as an essential cofactor to stabilizing endothelial nitric oxide (NO) synthase (eNOS) or through generalized antioxidant effects. We used the stereoisomer S-BH(4), which has the same antioxidant properties but does not function as an essential NOS cofactor, to elucidate the mechanism by which R-BH(4) restores cutaneous VD in HC humans. Intradermal microdialysis fibers were placed in 20 normocholesterolemic (NC), 13 midrange cholesterolemic (MC), and 18 HC (LDL: 94 ± 3, 124 ± 3 and 179 ± 6 mg/dl, respectively) men and women to perfuse Ringer (control site) and R-BH(4). In 10 NC, 13 MC, and 9 HC subjects (LDL: 94 ± 3, 124 ± 3, 180 ± 10 mg/dl), S-BH(4) was perfused at a third microdialysis site. Skin blood flow was measured during a standardized local heating protocol to elicit eNOS-dependent VD. After cutaneous vascular conductance (CVC = LDF/MAP) plateaued, NO-dependent VD was quantified by perfusing N(G)-nitro-l-arginine methyl ester (l-NAME). Data were normalized as %CVC(max). Fully expressed VD (NC: 97.9 ± 2.3 vs. MC: 85.4 ± 5.4, HC: 79.9 ± 4.2%CVC(max)) and the NO-dependent portion (NC: 62.1 ± 3 vs. MC: 45.8 ± 3.9, HC: 35.7 ± 2.8%CVC(max)) were reduced in HC (both P < 0.01 vs. NC), but only the fully expressed VD was reduced in MC (P < 0.01 vs. NC). R-BH(4) increased the fully expressed (93.9 ± 3.4%CVC(max); P < 0.01) and NO-dependent VD (52.1 ± 5.1%CVC(max); P < 0.01) in HC but not in NC or MC. S-BH(4) increased full-expressed VD in HC (P < 0.01) but did not affect NO-dependent VD in HC or MC. In contrast S-BH(4) attenuated NO-dependent VD in NC (control: 62.1 ± 3 vs. S-BH(4): 41.6 ± 7%CVC(max); P < 0.001). Exogenous R-BH(4) restores NO-dependent VD in HC human skin predominantly through NOS coupling mechanisms but increases full expression of the local heating response through generalized antioxidant properties.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aged
  • Analysis of Variance
  • Antioxidants / pharmacology
  • Biopterins / administration & dosage
  • Biopterins / analogs & derivatives*
  • Biopterins / pharmacology
  • Case-Control Studies
  • Cholesterol / blood
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / enzymology*
  • Hypercholesterolemia / physiopathology*
  • Laser-Doppler Flowmetry
  • Male
  • Microdialysis
  • Microvessels / drug effects*
  • Microvessels / enzymology
  • Microvessels / physiopathology
  • Middle Aged
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Nitric Oxide Synthase Type III / metabolism*
  • Regional Blood Flow / drug effects
  • Skin / blood supply*
  • Time Factors
  • Vasodilation / drug effects*
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / pharmacology*

Substances

  • Antioxidants
  • Enzyme Inhibitors
  • Vasodilator Agents
  • Biopterins
  • Nitric Oxide
  • Cholesterol
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • sapropterin
  • NG-Nitroarginine Methyl Ester